The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis
Abstract
Axonal damage is found in both acute and chronic lesions of multiple sclerosis. Direct axon counting in post-mortem tissue has suggested that smaller axons might have a greater susceptibility to damage, but methodological limitations have precluded unequivocal interpretation. However, as neuronal and axonal sizes are linked and neuronal changes would be expected with retrograde or transsynaptic degeneration following axon injury, we hypothesized that an alternative strategy for studying this phenomenon would be to define multiple sclerosis-associated changes in neurones. To test this hypothesis, we measured both axonal loss and neuronal size changes in the anterior optic pathway [including the optic nerve (ON), optic tract (OT) and lateral geniculate nucleus] of the brains of eight patients who died with multiple sclerosis and in eight control brains. The ONs and OTs in brains from the multiple sclerosis patients showed a trend to smaller mean cross-sectional areas (ON, multiple sclerosis = 6.84 mm(2), controls = 9.25 mm(2); and OT, multiple sclerosis = 6.45 mm(2), controls = 7.94 mm(2), P = 0.08) and had reduced axonal densities (ON, multiple sclerosis = 1.1 x 10(5)/mm(2), controls = 1.7 x 10(5)/mm(2); and OT, multiple sclerosis = 1.4 x 10(5)/mm(2), controls = 1.8 x 10(5)/mm(2), P = 0.006). Estimated total axonal counts were reduced by 32 (OT)-45% (ON) in the patients relative to controls (ON, multiple sclerosis = 8.1 x 10(5) axons, controls = 14.8 x10(5), P = 0.05; and OT, multiple sclerosis = 9.1 x 10(5), controls = 13.3 x 10(5), P = 0.02). The size distributions of the magnocellular cells in the lateral geniculate nucleus were similar for the two groups, but in multiple sclerosis brains the parvocellular cells were significantly smaller (mean sizes: multiple sclerosis = 226 microm(2), controls = 230 microm(2), P < 0.001) and had a larger variation in size, suggesting a greater proportion of atrophic neurones. Axon loss in the optic nerves of multiple sclerosis patients correlated strongly with measures of increased dispersion of cell sizes in the parvocellular layer (r = 0.8, P < 0.04). These data demonstrate that both atrophy and decreased density contribute to the substantial axonal loss in the anterior visual pathway of these patients. This appears related to a relatively selective atrophy of the smaller neurones of the parvocellular layer in the lateral geniculate nucleus, supporting the hypothesis that smaller axons may be preferentially susceptible to injury in multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898 · cited 4×
“MRI studies of the brain and cervical spinal cord in multiple sclerosis patients have shown a correlation between atrophy (representing axon and supporting tissue volume loss) and clinical disability (Losseff et al., 1996; Bitsch et al., 2000).”
BackgroundInfluentialDistinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Imaging axonal damage of normal-appearing white matter in multiple sclerosis
Fu, L. (1998) · Brain · doi:10.1093/brain/121.1.103 · Cited by 481
Progressive cerebral atrophy in multiple sclerosis A serial MRI study
Losseff, N. A., Wang, L., Lai, H. M., Yoo, D. S., Gawne-Cain, M. L., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.6.2009 · Cited by 479
Axonal pathology in multiple sclerosis: relationship to neurologic disability
Trapp, B. D., Ransohoff, R., & Rudick, R. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199906000-00008 · Cited by 475
Truyen, L., van Waesberghe, J. H. T. M., van Walderveen, M. A. A., van Oosten, B. W., Polman, C. H., Hommes, O. R., Ader, H. J. A., & Barkhof, F. (1996) · Neurology · doi:10.1212/wnl.47.6.1469 · Cited by 462
Evangelou, N. (2000) · Brain · doi:10.1093/brain/123.9.1845 · Cited by 416
Self-citationTHE NEUROPATHOLOGY OF MULTIPLE SCLEROSIS
Ludwin, S. K. (2000) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00665-3 · Cited by 329
Cited by
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Progressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Remyelination is extensive in a subset of multiple sclerosis patients
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., Bruck, W., Lucchinetti, C., & Lassmann, H. (2006) · Brain · doi:10.1093/brain/awl217 · Cited by 807
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747
Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
FISHER, J., JACOBS, D., MARKOWITZ, C., GALETTA, S., VOLPE, N., NANOSCHIAVI, M., BAIER, M., FROHMAN, E., WINSLOW, H., & FROHMAN, T. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.040 · Cited by 658
Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability
De Stefano, N., Matthews, P. M., Filippi, M., Agosta, F., De Luca, M., Bartolozzi, M. L., Guidi, L., Ghezzi, A., Montanari, E., Cifelli, A., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000055926.69643.03 · Cited by 489
Green, A. J., McQuaid, S., Hauser, S. L., Allen, I. V., & Lyness, R. (2010) · Brain · doi:10.1093/brain/awq080 · Cited by 487
Association between pathological and MRI findings in multiple sclerosis
Filippi, M., Rocca, M. A., Barkhof, F., Brück, W., Chen, J. T., Comi, G., DeLuca, G., De Stefano, N., Erickson, B. J., Evangelou, N., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70003-0 · Cited by 486
Self-citationAxonal damage: a key predictor of outcome in human CNS diseases
Medana, I. M., & Esiri, M. M. (2003) · Brain · doi:10.1093/brain/awg061 · Cited by 464
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Dutta, R., & Trapp, B. D. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.005 · Cited by 457
Axon pathology in neurological disease: a neglected therapeutic target
Coleman, M. P., & Perry, V. H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02255-5 · Cited by 389
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis
Talman, L. S., Bisker, E. R., Sackel, D. J., Long, D. A., Galetta, K. M., Ratchford, J. N., Lile, D. J., Farrell, S. K., Loguidice, M. J., Remington, G., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22005 · Cited by 366
The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects
Minagar, A., Barnett, M. H., Benedict, R. H. B., Pelletier, D., Pirko, I., Sahraian, M. A., Frohman, E., & Zivadinov, R. (2013) · Neurology · doi:10.1212/wnl.0b013e31827b910b · Cited by 326
Demyelination versus remyelination in progressive multiple sclerosis
Bramow, S., Frischer, J. M., Lassmann, H., Koch-Henriksen, N., Lucchinetti, C. F., Sørensen, P. S., & Laursen, H. (2010) · Brain · doi:10.1093/brain/awq250 · Cited by 319
Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment
Amato, M. P., Bartolozzi, M. L., Zipoli, V., Portaccio, E., Mortilla, M., Guidi, L., Siracusa, G., Sorbi, S., Federico, A., & De Stefano, N. (2004) · Neurology · doi:10.1212/01.wnl.0000129544.79539.d5 · Cited by 318
Pathology of multiple sclerosis and related inflammatory demyelinating diseases
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00002-9 · Cited by 303
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS
Sepulcre, J., Murie-Fernandez, M., Salinas-Alaman, A., García-Layana, A., Bejarano, B., & Villoslada, P. (2007) · Neurology · doi:10.1212/01.wnl.0000260612.51849.ed · Cited by 298
Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations
Moll, N. M., Rietsch, A. M., Thomas, S., Ransohoff, A. J., Lee, J., Fox, R., Chang, A., Ransohoff, R. M., & Fisher, E. (2011) · Annals of Neurology · doi:10.1002/ana.22521 · Cited by 297
The molecular basis of neurodegeneration in multiple sclerosis
Lassmann, H., & van Horssen, J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.004 · Cited by 294
Diffusion MRI in multiple sclerosis
Rovaris, M., Gass, A., Bammer, R., Hickman, S. J., Ciccarelli, O., Miller, D. H., & Filippi, M. (2005) · Neurology · doi:10.1212/01.wnl.0000184471.83948.e0 · Cited by 287
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis
De Stefano, N., Stromillo, M. L., Giorgio, A., Bartolozzi, M. L., Battaglini, M., Baldini, M., Portaccio, E., Amato, M. P., & Sormani, M. P. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309903 · Cited by 256
Trans‐synaptic axonal degeneration in the visual pathway in multiple sclerosis
Gabilondo, I., Martínez‐Lapiscina, E. H., Martínez‐Heras, E., Fraga‐Pumar, E., Llufriu, S., Ortiz, S., Bullich, S., Sepulveda, M., Falcon, C., Berenguer, J., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24030 · Cited by 255
Burkholder, B. M., Osborne, B., Loguidice, M. J., Bisker, E., Frohman, T. C., Conger, A., Ratchford, J. N., Warner, C., Markowitz, C. E., Jacobs, D. A., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.230 · Cited by 199
Review: Mitochondria and disease progression in multiple sclerosis
Mahad, D., Lassmann, H., & Turnbull, D. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00987.x · Cited by 193
Mechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167
Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis
Vogt, J., Paul, F., Aktas, O., Müller‐Wielsch, K., Dörr, J., Dörr, S., Bharathi, B. S., Glumm, R., Schmitz, C., Steinbusch, H., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21719 · Cited by 157
Anderson, J. M., Hampton, D. W., Patani, R., Pryce, G., Crowther, R. A., Reynolds, R., Franklin, R. J. M., Giovannoni, G., Compston, D. A. S., Baker, D., et al. (2008) · Brain · doi:10.1093/brain/awn119 · Cited by 141
Papadopoulos, D., Pham-Dinh, D., & Reynolds, R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.033 · Cited by 115
Axonal injury in multiple sclerosis
Lassmann, H. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.695 · Cited by 112
Progressive multiple sclerosis
Bradl, M., & Lassmann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0182-3 · Cited by 108
Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons
Riudavets, M. A., Iacono, D., Resnick, S. M., O’Brien, R., Zonderman, A. B., Martin, L. J., Rudow, G., Pletnikova, O., & Troncoso, J. C. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.005 · Cited by 106
“We believe that atrophy of the neuronal cell body reflects the shrinkage of the entire neuron, including its dendritic and axonal processes [15] in combination with loss of synapses [28], and is the cellular substrate of the cortical atrophy observed by neuroimaging or macroscopically.”
BackgroundThe histopathology of grey matter demyelination in multiple sclerosis
Bø, L. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01216.x · Cited by 58
VEP and PERG in patients with multiple sclerosis, with and without a history of optic neuritis
Janáky, M., Jánossy, Á., Horváth, G., Benedek, G., & Braunitzer, G. (2017) · Documenta Ophthalmologica · doi:10.1007/s10633-017-9589-7 · Cited by 24
Metadata
- Authors
- Evangelou, N.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-09-01
- Volume
- 124
- Issue
- 9
- Pages
- 1813-1820
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2167472069
- Cited by
- 323
- References
- 25
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.